Science Abstracts
Clinical immunotoxicity of therapeutic proteins
September 2010
September 2010
Authors : Jacques Descotes , Aurore Gouraud
Affliation : Centre Antipoison – Centre de Pharmacovigilance, 162 Avenue Lacassagne, 69424 Lyon cedex 03, France; ; jacques-georges.descotes@chu-lyon.fr
DOI : 10.1517/17425250802525496
Published in : Expert Opin. Drug Metab. Toxicol.
Subject:
Keywords: anti-TNF-α , drugs , autoimmunity , clinical immunotoxicology , cytokines , hypersensitivity , immunogenicity , immunostimulation , immunosuppression , monoclonal antibodies , therapeutic proteins
Abstract
Therapeutic proteins are proteins engineered in...
Please Login to read the full article.
RELATED CONTENT
NEWS
- Dendreon's Provenge becomes first therapeutic cancer vaccine to be approved in US
- US panel recommends Merck & Co's Gardasil for boys and men
- BMS's novel immunotherapy ipilimumab could gain US approval this year for melanoma
- "Hypersensitivity" and GI profile threaten Roche/Ipsen's taspoglutide
COMMENT
Other Informa Comment
EVENTS
01 January 1970
London, UK
01 January 1970
San Diego, US
01 January 1970
Providence, Rhode Island, and San Francisco, California
JOB OF THE WEEK
Promote your vacancy here
